CATX Stock Analysis: Buy, Sell, or Hold?
CATX - Perspective Therapeutics, Inc.
$3.11
-0.07 (-2.20%)
âŧ
5d:
-5.76%
30d:
+4.01%
90d:
-21.07%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When CATX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CATX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CATX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CATX is currently trading at $3.11, which is considered fair relative to its 30-day fair value range of $2.92 to $3.23.
Technical Outlook: Technically, CATX is in a strong downtrend. The price is currently testing key support at $3.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CATX scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.53 (+303.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CATX is in a strong downtrend. The price is currently testing key support at $3.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CATX scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.53 (+303.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.92 -
$3.23
Company Quality Score
44/100
(HOLD)
Options IV Signal
25th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 25th percentile)
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 303.0% below Wall St target ($12.53)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.92 -
$3.23
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$0.45
(14.3%)
Support & Resistance Levels
Support Level
$3.08
Resistance Level
$3.56
Current Trend
Strong Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.05
Wall Street Target
$12.53
(+303.0%)
Revenue Growth (YoY)
-72.1%
Share & Embed Analysis
Last updated: August 29, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CATX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 48 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 67 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 43 HOLD |
